AR081593A1 - Procedimiento de sintesis de la ferroquina por aminacion reductora convergente - Google Patents
Procedimiento de sintesis de la ferroquina por aminacion reductora convergenteInfo
- Publication number
- AR081593A1 AR081593A1 ARP110101985A ARP110101985A AR081593A1 AR 081593 A1 AR081593 A1 AR 081593A1 AR P110101985 A ARP110101985 A AR P110101985A AR P110101985 A ARP110101985 A AR P110101985A AR 081593 A1 AR081593 A1 AR 081593A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- railway
- synthesis procedure
- reducing amination
- convergent
- Prior art date
Links
- 230000015572 biosynthetic process Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000003786 synthesis reaction Methods 0.000 title abstract 2
- 238000005576 amination reaction Methods 0.000 title 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 239000002207 metabolite Substances 0.000 abstract 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 2
- DLYPREQTTOHKSM-UHFFFAOYSA-N 7-chloro-n-[[2-[(dimethylamino)methyl]cyclopenta-1,4-dien-1-yl]methyl]quinolin-4-amine;cyclopenta-1,3-diene;iron(2+) Chemical compound [Fe+2].C1C=CC=[C-]1.C1=[C-]CC(CN(C)C)=C1CNC1=CC=NC2=CC(Cl)=CC=C12 DLYPREQTTOHKSM-UHFFFAOYSA-N 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 abstract 1
- 239000007859 condensation product Substances 0.000 abstract 1
- 229950010451 ferroquine Drugs 0.000 abstract 1
- 239000012429 reaction media Substances 0.000 abstract 1
- 238000006268 reductive amination reaction Methods 0.000 abstract 1
- 230000002829 reductive effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F17/00—Metallocenes
- C07F17/02—Metallocenes of metals of Groups 8, 9 or 10 of the Periodic System
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F15/00—Compounds containing elements of Groups 8, 9, 10 or 18 of the Periodic Table
- C07F15/02—Iron compounds
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Quinoline Compounds (AREA)
Abstract
Reivindicación 1: Procedimiento de síntesis de la ferroquina de fórmula (F) o de su metabolito de fórmula (Fm) que comprende una reacción de aminación reductora, caracterizándose dicha reacción porque: (i) se condensa el aldehído-amino ferroceno de fórmula (3), en la que R representa un átomo de hidrógeno o un grupo metilo, con la 7-cloroquinolein-4-amina de fórmula (1); (ii) se reduce el producto de condensación así obtenido de fórmula (2), con R que representa un átomo de hidrógeno o un grupo metilo, (iii) se hidroliza el medio de reacción antes del aislamiento de la ferroquina de fórmula (F) o de su metabolito de fórmula (Fm).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1054625A FR2961209B1 (fr) | 2010-06-11 | 2010-06-11 | Procede de synthese de la ferroquine par amination reductrice convergente. |
Publications (1)
Publication Number | Publication Date |
---|---|
AR081593A1 true AR081593A1 (es) | 2012-10-03 |
Family
ID=42752115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP110101985A AR081593A1 (es) | 2010-06-11 | 2011-06-09 | Procedimiento de sintesis de la ferroquina por aminacion reductora convergente |
Country Status (24)
Country | Link |
---|---|
US (1) | US8497375B2 (es) |
EP (1) | EP2580224B1 (es) |
JP (2) | JP5916721B2 (es) |
KR (1) | KR101839634B1 (es) |
CN (1) | CN102939297B (es) |
AP (1) | AP3020A (es) |
AR (1) | AR081593A1 (es) |
AU (1) | AU2011263354B2 (es) |
BR (1) | BR112012031159A2 (es) |
CA (1) | CA2802161C (es) |
CL (1) | CL2012003455A1 (es) |
CO (1) | CO6602116A2 (es) |
EA (1) | EA020392B1 (es) |
FR (1) | FR2961209B1 (es) |
IL (1) | IL223521A (es) |
JO (1) | JO2928B1 (es) |
MA (1) | MA34363B1 (es) |
MX (1) | MX2012014473A (es) |
NZ (1) | NZ605608A (es) |
SG (1) | SG186247A1 (es) |
TW (1) | TWI485136B (es) |
UY (1) | UY33447A (es) |
WO (1) | WO2011154923A1 (es) |
ZA (1) | ZA201209328B (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2961209B1 (fr) | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
CN103242378B (zh) * | 2013-05-20 | 2015-06-03 | 洛阳师范学院 | 二茂铁基嘧啶钳形配体及其制备方法 |
CN103254250B (zh) * | 2013-05-20 | 2015-06-10 | 洛阳师范学院 | 二茂铁基吡嗪环钯氮杂环卡宾化合物及其制备方法和用途 |
CN103242379B (zh) * | 2013-05-20 | 2015-09-02 | 洛阳师范学院 | 2-二茂铁基-芳基喹啉及其制备方法 |
EP2821412A1 (en) * | 2013-07-01 | 2015-01-07 | Universität Zürich | Organometallic 2-cyano-2-aminobenzoate-propyl derivates and their use as anthelmintics |
CN103848872A (zh) * | 2014-03-20 | 2014-06-11 | 内蒙古大学 | 一种含二茂铁基团的中氮茚化合物的制备方法 |
US10370395B2 (en) | 2015-01-02 | 2019-08-06 | University Of Vermont And State Agricultural College | Cymanquine compounds and derivatives thereof and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3856850B2 (ja) * | 1994-08-18 | 2006-12-13 | 生化学工業株式会社 | 光学活性アミノケトン及びアミノアルコールの製造方法 |
FR2733985B1 (fr) * | 1995-05-10 | 1997-07-18 | Univ Lille Sciences Tech | Complexes organometalliques du fer antipaludiques |
JP3921703B2 (ja) * | 1995-07-12 | 2007-05-30 | 住友化学株式会社 | N−(α−アルキルベンジリデン)−α−フェニルアルキルアミン |
JPH09124576A (ja) * | 1995-10-27 | 1997-05-13 | Sumitomo Chem Co Ltd | イミン類の製造方法 |
US6777427B2 (en) * | 2000-09-14 | 2004-08-17 | Kaken Pharmaceutical Co., Ltd. | Tetrahydroquinoline compounds |
ATE449753T1 (de) * | 2002-02-07 | 2009-12-15 | Sumitomo Chemical Co | Verfahren zur herstellung von (r)-3-hydroxy-3-(2- phenylethyl) hexansäure und dessen zwischenprodukt |
FR2884715B1 (fr) * | 2005-04-20 | 2007-06-15 | Sanofi Aventis Sa | Association entre la ferroquine et un derive d'artemisinine pour le traitement du paludisme |
FR2961209B1 (fr) | 2010-06-11 | 2013-03-01 | Sanofi Aventis | Procede de synthese de la ferroquine par amination reductrice convergente. |
-
2010
- 2010-06-11 FR FR1054625A patent/FR2961209B1/fr active Active
-
2011
- 2011-06-09 AR ARP110101985A patent/AR081593A1/es unknown
- 2011-06-09 JO JO2011190A patent/JO2928B1/en active
- 2011-06-10 WO PCT/IB2011/052536 patent/WO2011154923A1/en active Application Filing
- 2011-06-10 EP EP11729738.2A patent/EP2580224B1/en active Active
- 2011-06-10 BR BR112012031159A patent/BR112012031159A2/pt not_active Application Discontinuation
- 2011-06-10 AU AU2011263354A patent/AU2011263354B2/en not_active Ceased
- 2011-06-10 CA CA2802161A patent/CA2802161C/en active Active
- 2011-06-10 MA MA35540A patent/MA34363B1/fr unknown
- 2011-06-10 TW TW100120422A patent/TWI485136B/zh not_active IP Right Cessation
- 2011-06-10 UY UY0001033447A patent/UY33447A/es not_active Application Discontinuation
- 2011-06-10 EA EA201291209A patent/EA020392B1/ru not_active IP Right Cessation
- 2011-06-10 NZ NZ605608A patent/NZ605608A/en not_active IP Right Cessation
- 2011-06-10 AP AP2012006595A patent/AP3020A/xx active
- 2011-06-10 CN CN201180028786.2A patent/CN102939297B/zh active Active
- 2011-06-10 KR KR1020127032234A patent/KR101839634B1/ko active IP Right Grant
- 2011-06-10 SG SG2012090502A patent/SG186247A1/en unknown
- 2011-06-10 JP JP2013513804A patent/JP5916721B2/ja active Active
- 2011-06-10 MX MX2012014473A patent/MX2012014473A/es active IP Right Grant
-
2012
- 2012-12-07 CL CL2012003455A patent/CL2012003455A1/es unknown
- 2012-12-09 IL IL223521A patent/IL223521A/en active IP Right Grant
- 2012-12-10 ZA ZA2012/09328A patent/ZA201209328B/en unknown
- 2012-12-10 US US13/709,710 patent/US8497375B2/en active Active
- 2012-12-11 CO CO12223884A patent/CO6602116A2/es not_active Application Discontinuation
-
2016
- 2016-02-10 JP JP2016023254A patent/JP2016145214A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR081593A1 (es) | Procedimiento de sintesis de la ferroquina por aminacion reductora convergente | |
CL2012000494A1 (es) | Composición para reducir los efectos perjudiciales y/o eliminar la aparición de micotoxina que comprende un polímero de impresión molecular sintetizado utilizando una plantilla de micotoxina de fórmula específica. | |
BRPI1012638B8 (pt) | métodos e intermediários para preparar agentes farmacêuticos | |
AR068501A1 (es) | Formulacion de resina fenolica y recubrimientos para productos abrasivos | |
CR10955A (es) | Nuevo procedimiento de sintesis de la agomelatina | |
EA201270280A1 (ru) | Соединения пиримидина в качестве ингибиторов при лечении туберкулеза | |
UY31883A (es) | Nuevo procedimiento de síntesis de 7,8-dimetoxi-1, 3-dihidro-2h-3-benzazepin-2-ona, y aplicación en la síntesis de ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
CR10960A (es) | Nuevo procedimiento de sintesis de la agomelatina | |
MX2011007978A (es) | Nuevo procedimiento de sintesis de la ivabradina y de sus sales de adicion a un acido farmaceuticamente aceptable. | |
AR058253A1 (es) | Procedimiento para la preparacion de ferri-succinilcaseina | |
CO6450620A2 (es) | Sales de 6´ -sialil-lactosa y procesos para su sintesis y para la sintesis de otros alfa-sialil-oligosacaridos | |
CY1115577T1 (el) | Μεθοδος για την παρασκευη εναντιομερικως καθαρων αμινων | |
UY32499A (es) | Nuevo procedimiento de síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
TN2011000355A1 (en) | Novel microbiocides | |
CR20120056A (es) | Proceso para la preparación de amidas del ácido pirazol carboxílico. | |
CR20110208A (es) | Proceso para la preparación de benzonorbornenos | |
CR10934A (es) | Nuevo procedimiento de sintesis de la agomelatina | |
UY32042A (es) | Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90 | |
ECSP10010505A (es) | Composición farmacéutica | |
CL2010000254A1 (es) | Procedimiento de sintesis de ivabradina por formacion de una imina; y los compuestos intermediarios considerados en el procedimiento. | |
CR10952A (es) | Nuevo procedimiento de obtencion de la forma cristalina v de la agomelatina | |
MY160625A (en) | Process for preparing pan-cdk inhibitors of the formula(i), and intermediates in the preparation | |
UY31398A1 (es) | Proceso para sintetizar compuestos de ácido fosfónico y posfínico | |
UY35561A (es) | Procedimiento de síntesis del 3,4-dimetoxibiciclo[4.2.0]octa-1,3,5-trien-7- carbonitrilo, y aplicación a la síntesis de la ivabradina y de sus sales de adición a un ácido farmacéuticamente aceptable | |
MX2011009734A (es) | Nuevo procedimiento de preparacion de compuestos de enaminocarbonilio. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |